Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 2000; Volume 57,Issue 2

MINIREVIEW

  • You have access
    Accommodating Protein Flexibility in Computational Drug Design ,
    Heather A. Carlson and J. Andrew McCammon
    Molecular Pharmacology February 2000, 57 (2) 213-218;

Articles

  • You have access
    Mutational Analysis of the Highly Conserved Arginine within the Glu/Asp-Arg-Tyr Motif of the α1b-Adrenergic Receptor: Effects on Receptor Isomerization and Activation
    Alexander Scheer, Tommaso Costa, Francesca Fanelli, Pier G. De Benedetti, Sakina Mhaouty-Kodja, Liliane Abuin, Monique Nenniger-Tosato and Susanna Cotecchia
    Molecular Pharmacology February 2000, 57 (2) 219-231;
  • You have access
    Molecular and Conformational Features of a Transport-Relevant Domain in the C-Terminal Tail of the Vasopressin V2Receptor
    Gerd Krause, Ricardo Hermosilla, Alexander Oksche, Claudia Rutz, Walter Rosenthal and Ralf Schülein
    Molecular Pharmacology February 2000, 57 (2) 232-242;
  • You have access
    7- and 10-Substituted Camptothecins: Dependence of Topoisomerase I-DNA Cleavable Complex Formation and Stability on the 7- and 10-Substituents
    Bogdan Vladu, Jan M. Woynarowski, Govindarajan Manikumar, Mansukhlal C. Wani, Monroe E. Wall, Daniel D. Von Hoff and Randy M. Wadkins
    Molecular Pharmacology February 2000, 57 (2) 243-251;
  • You have access
    β1-Adrenergic Receptors Mediate β3-Adrenergic-Independent Effects of CGP 12177 in Brown Adipose Tissue
    Anish A. Konkar, Ying Zhai and James G. Granneman
    Molecular Pharmacology February 2000, 57 (2) 252-258;
  • You have access
    Functional Domains and Expression of Truncated Atrial Natriuretic Peptide Receptor-A: The Carboxyl-Terminal Regions Direct the Receptor Internalization and Sequestration in COS-7 Cells
    Kailash N. Pandey, Ravindra Kumar, Ming Li and Huong Nguyen
    Molecular Pharmacology February 2000, 57 (2) 259-267;
  • You have access
    Molecular Determinants of Mexiletine Structure for Potent and Use-Dependent Block of Skeletal Muscle Sodium Channels
    Annamaria De Luca, Fedele Natuzzi, Jean-Francois Desaphy, Gabriella Loni, Giovanni Lentini, Carlo Franchini, Vincenzo Tortorella and Diana Conte Camerino
    Molecular Pharmacology February 2000, 57 (2) 268-277;
  • You have access
    Mechanisms of Impaired β-Adrenergic Receptor Signaling in Gαq-Mediated Cardiac Hypertrophy and Ventricular Dysfunction
    Gerald W. Dorn, Nicole M. Tepe, Guangyu Wu, Atsuko Yatani and Stephen B. Liggett
    Molecular Pharmacology February 2000, 57 (2) 278-287;
  • You have access
    Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro
    Christopher W. Vaughan, Mark Connor, Elena E. Bagley and MacDonald J. Christie
    Molecular Pharmacology February 2000, 57 (2) 288-295;
  • You have access
    Selection of Human Leukemic CEM Cells for Resistance to the DNA Topoisomerase II Catalytic Inhibitor ICRF-187 Results in Increased Levels of Topoisomerase IIα and Altered G2/M Checkpoint and Apoptotic Responses
    Susan E. Morgan, Rhonda S. Cadena, Susana C. Raimondi and William T. Beck
    Molecular Pharmacology February 2000, 57 (2) 296-307;
  • You have access
    Photoaffinity Labeling and Purification of ZG-16p, a High-Affinity Dihydropyridine Binding Protein of Rat Pancreatic Zymogen Granule Membranes that Regulates a K+-Selective Conductance
    Matthias Braun and Frank Thévenod
    Molecular Pharmacology February 2000, 57 (2) 308-316;
  • You have access
    Role of the Amino Acid 45 Residue in Reduced Folate Carrier Function and Ion-Dependent Transport as Characterized by Site-Directed Mutagenesis
    Rongbao Zhao, Feng Gao, Pi Jun Wang and I. David Goldman
    Molecular Pharmacology February 2000, 57 (2) 317-323;
  • You have access
    Basic Fibroblast Growth Factor Sensitizes NIH 3T3 Cells to Apoptosis Induced by Cisplatin
    Aaron B. Coleman, Jamil Momand and Susan E. Kane
    Molecular Pharmacology February 2000, 57 (2) 324-333;
  • You have access
    Eosine-Induced Blockade ofN-Methyl-d-aspartate Channels in Acutely Isolated Rat Hippocampal Neurons
    Alexander I. Sobolevsky, Maria V. Yelshansky and Boris I. Khodorov
    Molecular Pharmacology February 2000, 57 (2) 334-341;
  • You have access
    Alterations in Subunit Expression, Composition, and Phosphorylation of StriatalN-Methyl-d-Aspartate Glutamate Receptors in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
    Anthone W. Dunah, Yuehua Wang, Robert P. Yasuda, Kimihiko Kameyama, Richard L. Huganir, Barry B. Wolfe and David G. Standaert
    Molecular Pharmacology February 2000, 57 (2) 342-352;
  • You have access
    Differential Regulation of Prostaglandin F2αReceptor Isoforms by Protein Kinase C
    Hiromichi Fujino, Dinesh Srinivasan, Kristen L. Pierce and John W. Regan
    Molecular Pharmacology February 2000, 57 (2) 353-358;
  • You have access
    Drug-Resistant Variants of Escherichia coliThymidylate Synthase: Effects of Substitutions at Pro-254
    Corinne Fantz, David Shaw, William Jennings, Antonia Forsthoefel, Maria Kitchens, Jason Phan, Wladek Minor, Lukasz Lebioda, Franklin G. Berger and H. Trent Spencer
    Molecular Pharmacology February 2000, 57 (2) 359-366;
  • You have access
    Molecular Determinant of High-Affinity Dofetilide Binding toHERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites
    James P. Lees-Miller, Yanjun Duan, Guo Qi Teng and Henry J. Duff
    Molecular Pharmacology February 2000, 57 (2) 367-374;
  • You have access
    The Impact of Functional Vitamin D3 Receptor Conformations on DNA-Dependent Vitamin D3 Signaling
    Marcus Quack and Carsten Carlberg
    Molecular Pharmacology February 2000, 57 (2) 375-384;
  • You have access
    A Designed Peptidomimetic Agonistic Ligand of TrkA Nerve Growth Factor Receptors
    Sergei Maliartchouk, Yangbo Feng, Ljubica Ivanisevic, Thomas Debeir, A. Claudio Cuello, Kevin Burgess and H. Uri Saragovi
    Molecular Pharmacology February 2000, 57 (2) 385-391;
  • You have access
    Selective Block of Late Currents in the ΔKPQ Na+Channel Mutant by Pilsicainide and Lidocaine with Distinct Mechanisms
    Katsushige Ono, Toshihiko Kaku, Naomasa Makita, Akira Kitabatake and Makoto Arita
    Molecular Pharmacology February 2000, 57 (2) 392-400;
  • You have access
    Post-Transcriptional Regulation of Mouse κ-Opioid Receptor Expression
    Li-Na Wei, Xinli Hu, Jing Bi and Horace Loh
    Molecular Pharmacology February 2000, 57 (2) 401-408;
  • You have access
    Huprine X is a Novel High-Affinity Inhibitor of Acetylcholinesterase That Is of Interest for Treatment of Alzheimer's Disease
    Pelayo Camps, Bernadette Cusack, William D. Mallender, Rachid El Achab, Jordi Morral, Diego Muñoz-Torrero and Terrone L. Rosenberry
    Molecular Pharmacology February 2000, 57 (2) 409-417;
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 57 (2)
Molecular Pharmacology
Vol. 57, Issue 2
1 Feb 2000
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • MINIREVIEW
  • Articles
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Wnt Signaling and Drug Resistance in Cancer
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics